Introduction. Latent membrane protein 2A is an Epstein-Barr virus encoded transmembrane protein that is implicated in the regulation of viral latency and pathogenesis [1, 2] . LMP2A recruits a set of cellular proteins such as tyrosine protein kinases Lyn and Syk to activate Akt-and Ras-dependent signaling pathways in epithelial and B cells [3] [4] [5] . LMP2A resembles BCR (B cell receptor) by the presence of ITAM (Immunoreceptor tyrosine-based activation motif) in the N-terminal cytosolic domain [6, 7] . In contrast to BCR, LMP2A contains adjacent to ITAM several PY motifs which recruit Nedd4 family ubiquitin-protein ligases (E3s) resulting in the downregulation of LMP2A activity by ubiquitylation of LMP2A and LMP2A-associated kinases [8, 9] .
Recently it has been shown that E3 ubiquitin ligase CBL ubiquitylates LMP2A and associated with LMP2A kinases, but no direct interaction between CBL and LMP2A has been reported so far [10] . Since both CBL and LMP2A are known to bind endocytic adaptor protein intersectin 1 (ITSN1) [11] [12] [13] , we asked whether ITSN1 could mediate the interaction between these two proteins. ITSN1 is a multidomain adaptor protein implicated in endocytosis, regulation of signaling networks and actin cytoskeleton rearrangements [14, 15] . Due to the presence of numerous modules of proteinprotein interaction ITSN1 functions as a platform to assemble multi-component complexes [16, 17] .
Materials and methods. Antibodies. Monoclonal antibody to the FLAG epitope (clone M2) was from «Sigma» (USA); monoclonal a-Omni (D-8) antibody was from «Santa Cruz Biotechnology» (USA); a mono-clonal a-HA (MMS-101P) was from Covance. Mouse a-Intersectin/ESE-1 monoclonal antibody (611574) was from «BD Transduction Laboratories» (USA). For immunofluorescence goat a-rabbit Alexa 405 («Invit-rogen», USA) and horse a-mouse FITC-conjugated («Vector Laboratories», USA) antibodies were used.
Cell culture and transfection. HEK293 and MCF-7 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10 % fetal calf serum, 50 U/ml penicillin and 100 mg/ml streptomycin. Transfections were carried out as described previously [18] . HEK293 cells stably transfected with wild type LMP2A or empty vector were generated using linearized pcDNA4/HisMax-LMP2A or pcDNA4/HisMax vector, respectively.
Transfected cells were selected on 160 mg/ml zeocin («Invitrogen») for 7 days.
Plasmids. Omni-ITSN1 was described previously [19] , FLAG-LMP2A was a generous gift of Dr. G. Winberg (Karolinska Institute, Sweden), Omni-LMP2A and Omni-LMP2A YF + P5 mutant were described previously [13] , mCherry-ITSN1 was described in [20] . Omni-HA-CBL wild-type and Omni-HA-tagged G306E mutant were obtained by cloning a full-length wild-type CBL or respective mutant carrying on their 5'end sequence of HA-tag, provided by Dr. H. Band (University of Nebraska, USA) in pcDNA4/HisMax C vector («Invitrogen»).
Immunoprecipitation and Western blot analysis were carried out as described previously [13] .
Immunofluorescence and confocal microscopy. MCF-7 cells were plated on coverslips and transfected with plasmids encoding FLAG-LMP2A, Omni-HA-CBL and mCherry-ITSN1 using the JetPEI reagent. 24 h posttransfection cells were washed with ice-cold PBS, fixed in 4 % formaldehyde for 15 min, then washed 3 times with 1 ´ PBS and 0.2 % Triton X-100 for 5 min and blocked in 2 % BSA for 30 min at room temperature. The cells were incubated with the mixture of aOmni (rabbit) and a-FLAG (mouse) primary antibody (dilution 1:100) for 1 h at room temperature. Staining with a-FLAG pAb was detected with FITC-conjugated a-mouse immunoglobulin (dilution 1:400), and a-Omni was detected with Alexa Fluor 405 conjugated a-rabbit Ig (dilution 1:400).
The slides were mounted using PVA-DABCO («Flu-ka», Switzerland), confocal images were taken with a Zeiss LSM510 microscope and analyzed using the LSM510 image browser software. Image of colocalized pixels were obtained using ImageJ 1.39p software, Colocalization plugin.
Results and discussion. CBL is a RING FINGER E3 ubiquitin ligase that is required for targeting substrates to the proteasomal degradation [21] . This protein contains the N-terminal phosphotyrosine binding domain (PTB) that enables its interaction with numerous tyrosine-phosphorylated substrates, catalytic RING FINGER domain, which is responsible for the ubiquitin ligase activity, multiple proline-rich motifs and Cterminal ubiquitin-associated (UBA) domain [22, 23] . The domain structure of CBL implies its association with LMP2A via PTB domain or involvement of additional adaptor protein.
The PTB domain of CBL is known to bind directly phosphotyrosines of receptors such as EGFR [22] , so we assumed that this domain could mediate CBL interaction with LMP2A as well. We observed a coimmunoprecipitation of LMP2A with a wild type CBL in contrast to its G306E mutant which has PTB domain unable to interact with phosphotyrosines ( Fig. 1 ). These findings suggest a role of PTB domain of CBL as a bin- ding site for LMP2A tyrosine-phosphorylated motifs. However, LMP2A YF + P5 mutant harboring mutations in the ITAM motif was readily coprecipitated with CBL. This data suggest that the interaction of CBL and LMP2A does not depend on phosphotyrosines of ITAM and could be mediated by other tyrosine-phosphorylated sites.
As mentioned above we can not exclude the involvement of some adaptor protein which could mediate the interaction between CBL and LMP2A. We suggested that ITSN1 could serve as such adaptor, since it was found to bind CBL [11, 12] as well as LMP2A [13] via different SH3 domains.
To address a possibility of the mutual complex formation of ITSN1, CBL and LMP2A immunoflurescence analysis was carried out. Multiple overlapping of ITSN1 and CBL signals was observed in MCF-7 cells, a certain portion of them was found to be LMP2A-positive (Fig.  2, see inset) .
Almost all CBL spots were ITSN1-positive, which is in line with previous finding that ITSN1 is constitutively associated with CBL [11] . Triple colocalization supports the idea about formation of the complex containing ITSN1, CBL and LMP2A.
To study a role of ITSN1 as a potential recruiter of CBL to LMP2A, ITSN1 was overexpressed in HEK293 cells stably expressing LMP2A and transiently cotransfected with CBL. We observed the significant increase in ITSN1 amount in the complex with CBL after ITSN1 overexpression, but the amount of LMP2A coprecipitated with CBL was barely affected, p = 0.86 (Fig. 3, A, B) . In line with this observation is the fact that a mutant of LMP2A (YF + P5) unable to bind ITSN1 [13] was readily detected in complex with CBL (Fig. 3, C) . Taken together these results we assume that ITSN1 might be engaged in the complex of CBL and LMP2A, but it is not required to mediate this interaction. This notion can be additionally supported by observed colocalization of LMP2A and CBL signals with no overlapping with ITSN1 (Fig. 2, see inset, upper  panel) .
Previous attempts to detect direct or indirect interaction of CBL with LMP2A were unsuccessful [10] and reasons for this failure remain unclear. A possible explanation of this fact might be the usage of different detergents in cell lysis buffers.
CBL is shown to promote LMP2A degradation through the ubiquitylation and specifically mediates the degradation of tyrosine kinase Syk in the presence of LMP2A. These events were found to be important for the regulation of EBV switch from the latency to the lytic phase of infection [10] . Our recent data point that ITSN1 interacts with the Syk kinase, moreover, it undergoes tyrosine phosphorylation by this kinase in LMP2A-positive cells [13] . As CBL controls Syk stability it may regulate ITSN1 phosphorylation as well. Noteworthy, CBL interacts with LMP2A via its PTB domain suggesting that this binding depends on phosphorylation of tyrosine residues of LMP2A. The interaction of CBL with LMP2A resembles its binding to a receptor molecule that occurs only when the latter has been phosphorylated. 
